• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Performance Management / FDA-TRACK Initiative

Description: Develop, implement, and execute the agency-wide FDA-TRACK performance management system.

Accomplishment: FDA-TRACK is our Agency's new performance management system and is a federal level adaptation of successful performance management programs from the state and local level. The FDA’s Office of Planning (OPL) organizes and coordinates FDA-TRACK with all of the 114 program offices through key performance measures and projects. Each quarter, the OPL team analyzes the monthly performance data and the program senior managers present this data to the FDA senior leadership. A description of FDA-TRACK and all of our Agency's measures, data and briefing summaries are updated each month on the FDA-TRACK website at http://www.fda.gov/fdatrack.

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

A. Complete the plan for full agency rollout


Completed 11/30/2009

B. Complete the quarterly briefing process for piloted offices


Completed 12/18/2009

C. Implement all offices onto FDA-TRACK


Completed 4/2/2010

D. Execute on full quarterly meetings for entire agency


Completed 6/30/2010

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.


Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.